AULSF
Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. The company operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables … Read more
Market Cap & Net Worth: AULSF (AULSF)
AULSF (PINK:AULSF) has a market capitalization of $35.88 Million ($35.88 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #28754 globally and #9566 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AULSF's stock price $0.07 by its total outstanding shares 512582000 (512.58 Million).
AULSF Market Cap History: 2024 to 2025
AULSF's market capitalization history from 2024 to 2025. Data shows growth from $2.56 Million to $35.88 Million (0.00% CAGR).
AULSF Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AULSF's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
AULSF's market cap is 0.00 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.16x
AULSF's market cap is 0.16 times its annual earnings
1.95x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $2.56 Million | $1.50 Billion | $16.08 Million | 0.00x | 0.16x |
Competitor Companies of AULSF by Market Capitalization
Companies near AULSF in the global market cap rankings as of March 19, 2026.
Key companies related to AULSF by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
AULSF Historical Marketcap From 2024 to 2025
Between 2024 and today, AULSF's market cap moved from $2.56 Million to $ 35.88 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $35.88 Million | +1300.00% |
| 2024 | $2.56 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of AULSF was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.88 Million USD |
| MoneyControl | $35.88 Million USD |
| MarketWatch | $35.88 Million USD |
| marketcap.company | $35.88 Million USD |
| Reuters | $35.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.